Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Flight MH370: Are Officials Close to Solving the Mystery?
48:29 - Association of Asia-Pacific Airlines Director General Andrew Herdman discusses the search for missing Malaysia Airlines flight MH370 and the debris that washed ashore on Reunion Island that could be from the missing plane. He speaks to Bloomberg’s Rishaad Salamat on “Trending Business.” (Source: Bloomberg)
  • China’s Caixin Manufacturing PMI 47.8; Est. 48.3
  • What Caused the TPP Talks to Fall Apart?
  • China PMI Showed 'No Love for Commodities': Gordon